168 related articles for article (PubMed ID: 4727056)
1. Carcinoembryonic antigen in serum in diseases of the liver and pancreas.
Khoo SK; Mackay IR
J Clin Pathol; 1973 Jul; 26(7):470-5. PubMed ID: 4727056
[TBL] [Abstract][Full Text] [Related]
2. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract.
Harmenberg U; Wahren B; Wiechel KL
Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472
[TBL] [Abstract][Full Text] [Related]
3. [Studies on serum CEA levels measured by enzyme immunoassay using monoclonal CEA-antibodies].
Takada S; Hoshi H; Ito F; Imai K; Yachi A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1487-91. PubMed ID: 6378102
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of carcinogenic embryonic antigen in differential diagnosis of diseases of pancreas and liver--a comparative study in a tertiary care hospital of Western Nepal.
Mittal A; Farooqui SM; Pyrtuh S; Poudel B; Sathian B; Yadav SK
Asian Pac J Cancer Prev; 2012; 13(1):275-7. PubMed ID: 22502684
[TBL] [Abstract][Full Text] [Related]
5. [Assay of the carcinoembryonic antigen (CEA) in acute and chronic liver diseases and hepatocellular carcinoma].
Piantino P; Gallo V; Pecchio F; Garlanda PF; Bonardi O
Minerva Med; 1981 Apr; 72(17):1059-64. PubMed ID: 6262678
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states.
Loewenstein MS; Zamcheck N
Cancer; 1978 Sep; 42(3 Suppl):1412-8. PubMed ID: 361200
[TBL] [Abstract][Full Text] [Related]
7. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
Tappero G; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K
Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
[TBL] [Abstract][Full Text] [Related]
9. [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers].
Takemori Y; Sawabu N; Satomura Y; Ohta H; Watanabe H; Okai T; Mai M; Hattori N; Akiyama T; Hashimoto T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):119-26. PubMed ID: 3541791
[TBL] [Abstract][Full Text] [Related]
10. Serum beta-N-acetyl hexosaminidase (beta-NAH) as a discriminant between malignant and benign extrahepatic biliary obstruction: comparison with carcinoembryonic antigen (CEA).
Scapa E; Thomas P; Loewenstein MS; Zamcheck N
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1037-42. PubMed ID: 2933260
[TBL] [Abstract][Full Text] [Related]
11. Identification of carcinoembryonic antigen (CEA) in bile of patients with malignant biliary tract disease.
Konomi K; Nakamura K; Tobimatsu M; Saito S; Toyoda K; Yasunami Y
Jpn J Surg; 1982; 12(3):184-90. PubMed ID: 7131963
[TBL] [Abstract][Full Text] [Related]
12. Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and age.
Basso D; Fabris C; Del Favero G; Angonese C; Meggiato T; Infantino A; Plebani M; Piccoli A; Leandro G; Burlina A
Dis Markers; 1988; 6(3):203-7. PubMed ID: 3168400
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.
Haglund C; Roberts PJ; Kuusela P; Scheinin TM; Mäkelä O; Jalanko H
Br J Cancer; 1986 Feb; 53(2):197-202. PubMed ID: 3456787
[TBL] [Abstract][Full Text] [Related]
14. Elevated carcinoembryonic antigen levels and biliary tract obstruction.
Lurie BB; Loewenstein MS; Zamcheck N
JAMA; 1975 Jul; 233(4):326-30. PubMed ID: 1173645
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen in whole serum.
MacSween JM; Warner NL; Bankhurst AD; Mackay IR
Br J Cancer; 1972 Oct; 26(5):356-60. PubMed ID: 4117478
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen in normal and diseased liver tissue.
Gerber MA; Thung SN
Am J Pathol; 1978 Sep; 92(3):671-9. PubMed ID: 356625
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction.
Del Favero G; Fabris C; Panucci A; Basso D; Plebani M; Baccaglini U; Leandro G; Burlina A; Naccarato R
Bull Cancer; 1986; 73(3):251-5. PubMed ID: 3530354
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen (CEA) in patients with malignant and non-malignant diseases.
Alsabti EA; Kamel A
Neoplasma; 1979; 26(5):603-9. PubMed ID: 230422
[TBL] [Abstract][Full Text] [Related]
19. Serum and pancreatic juice carcinoembryonic antigen in pancreatic and biliary disease.
Carr-Locke DL
Gut; 1980 Aug; 21(8):656-61. PubMed ID: 7429329
[TBL] [Abstract][Full Text] [Related]
20. Measurement of secretory IgA in serum by radioimmunoassay in patients with chronic nonalcoholic liver disease or carcinoma.
Homburger HA; Casey M; Jacob GL; Klee GG
Am J Clin Pathol; 1984 May; 81(5):569-74. PubMed ID: 6720627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
